ELIQUIS
Swiss trademark · 569602 · Word mark · In force
Register entry
- Registration number
- 569602
- Application number
- 64235/2007
- Status
- In force
- Type
- Word mark
- Filed
- Dec 14, 2007
- Registered
- Mar 26, 2008
- Published
- Apr 9, 2008
- Protected until
- Dec 14, 2027
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate für die Prävention und Behandlung von kardiovaskulären Krankheiten, ausgenommen diagnostische Produkte für den medizinischen, veterinärmedizinischen und wissenschaftlichen Gebrauch.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 14, 2023
Agent’s address changed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 14.12.2023
- Feb 1, 2021
Holder’s address changed
- Owner
- Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen → Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen
Published in Swissreg on 01.02.2021
- Aug 16, 2017
Renewed
Published in Swissreg on 16.08.2017
- Jul 22, 2016
Transferred
- Owner
- Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen
Published in Swissreg on 22.07.2016
- Apr 29, 2011
Transferred
- Owner
- Pfizer Products Inc., Eastern Point Road, CT 06340 Groton, USA → Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA
Published in Swissreg on 29.04.2011
- Apr 9, 2008
Registered
Published in the SOGC no. 68 of 09.04.2008
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.